Skip to main content
. 2016 Jun 1;10:139. doi: 10.3389/fncel.2016.00139

FIGURE 6.

FIGURE 6

Ischemia-derived astrocyte phenotype persistence requires gamma secretase activity. (A) Representative images of eGFP-IDA cell cultures of 7 DIV showing the phenotypical transformation from the fusiform morphology to the stellated morphology induced by the 48 h-treatment with the gamma secretase inhibitor DAPT; control cells received vehicle; bar = 25 μm. (B) Relative abundance of GFAP immunostained astrocytes in the eGFP IDA cultures after treatment with different DAPT concentrations. Statistical significance was confirmed with the non-parametric Kruskal–Wallis test and Dunn’s Multiple Comparison Test (*p < 0.05).